Vascular Solutions (VASC) Tops Q2 EPS by 3c, Updates FY Guidance

Vascular Solutions (NASDAQ: VASC) reported Q2 EPS of $0.33, $0.03 better than the analyst estimate of $0.30. Revenue for the quarter came in at $41.2 million versus the consensus estimate of $41.4 million.

GUIDANCE:

Vascular Solutions sees FY2016 EPS of $1.22-$1.26, versus the consensus of $1.21. Vascular Solutions sees FY2016 revenue of $164-166 million, versus the consensus of $164.8 million.

For earnings history and earnings-related data on Vascular Solutions (VASC) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance
• Jaguar Health (JAGX) Tops Q2 EPS by 3647c